Skip to main content

Madison Dearborn Acquires Majority Stake In Alcami

Alcami Corporation, a provider of fully-integrated custom end-to-end solutions for the pharmaceutical and biotechnology industries, today announced it has reached an agreement to be acquired by Madison Dearborn Partners. MDP will acquire a majority ownership position in Alcami from existing shareholder Ares Capital Corporation. Alcami's management team, led by Chief Executive Officer, President, and Chairman, Dr. Stephan Kutzer, will continue to guide the Company. The transaction is expected to be completed in the third quarter of 2018, pending customary closing conditions. "The entire Alcami team is excited to further enhance and evolve the small to mid-size pharma growth engine. As we enter our...